Obvious Ventures

The speaker recalls joining the early ranks of clean energy entrepreneurs 15 years ago, when oil was $15 per barrel, An Inconvenient Truth had not been released, and solar panels powered calculators.

Mithrl, an AI infrastructure company for biopharma, raises a $20 million Series A led by Obvious Ventures, CEO Vivek Adarsh tells Axios. The company integrates its proprietary biomedical world model with pharmaceutical companies’ R&D systems.

Sep 2026 · AxiosNews article

Obvious Ventures raises its fifth fund, $360,360,360, framing the amount around its focus on planetary, human, and economic health. Co-founder and managing director James Joaquin says the firm keeps funds small enough for one durable public company to return an entire fund; it plans about 10 investments a year, with $5 million to $12 million checks for seed and Series A startups. Portfolio examples include Zanskar, Inceptive, and Dexterity Robotics.

Jan 2026 · TechCrunchNews article

Nue Life Health opens its ketamine-therapy tracking app and Nue Score free to U.S. patients receiving treatment from any provider. The app integrates Apple HealthKit and Google Fit and supports patients using ketamine lozenges, intramuscular injections, or intravenous treatment. Nue Life says it has completed an additional $1.9 million financing round to support the rollout and delivers at-home ketamine therapy to more than 8,000 patients across the U.S.

Jun 2023 · TechCrunchNews article